
Sign up to save your podcasts
Or


Welcome to PhageLine. In this week's episode, we will focus on one of the biggest phage papers in 2024: a multicentre, multinational, retrospective observational study of personalized bacteriophage therapy outcomes for 100 consecutive cases headed by Jean-Paul Pirnay and Sarah Djebara.
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
By Planomicrobium massiliensisWelcome to PhageLine. In this week's episode, we will focus on one of the biggest phage papers in 2024: a multicentre, multinational, retrospective observational study of personalized bacteriophage therapy outcomes for 100 consecutive cases headed by Jean-Paul Pirnay and Sarah Djebara.
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.